Aligos Therapeutics, Inc. (ALGS) Tops Q2 EPS by 19c

Aligos Therapeutics, Inc. (NASDAQ: ALGS) reported Q2 EPS of $0.03, $0.19 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Aligos Therapeutics, Inc. (ALGS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Broadcom (AVGO) spreader of September 220 and 360 puts
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand